Background Lung cancer is the leading cause of cancer-related mortality worldwide. Low-
dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals …

Simple Summary Non-small cell lung cancer (NSCLC) is a common diagnosis from which
many patients die. Blood tests reflecting systemic inflammation are routinely collected in the …

Inflammation-related parameters serve as pivotal indicators in the prognosis and
management of lung cancer. This retrospective investigation aimed to explore the …

Background Systemic inflammation, the most representative tumour–host interaction, plays a
crucial role in disease progression and prognosis in patients with non‐small cell lung cancer …

Background Inflammation-scores based on general inflammation markers are suggested as
prognostic markers of overall survival (OS) in lung cancer. However, whether these …

Systemic inflammation and activation of haemostasis are common in patients with lung
cancer. Both conditions support tumour growth and metastasis. Therefore, inflammatory and …

The aim of this study was to investigate and analyse the predictive value of systemic
inflammatory markers based on peripheral blood biomarkers for the prognosis of non-small …

Background The advent of low-dose helical computed tomography for lung cancer
screening will likely lead to an increase in the detection of stage I lung cancer. Presently …

Background This prospective study was designed to investigate the association between ten
circulating inflammatory biomarkers and the risk for early stage lung adenocarcinoma …

Simple Summary Selection of appropriate high-risk smokers is one of the major challenges
for implementing low-dose computed tomography screening for lung cancer. Many lung …